Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer
Abstract Background The safety of thoracic radiotherapy (TRT) after programmed death 1/programmed death ligand 1 (PD‐(L)1) inhibitor treatment in patients with lung cancer was scarcely reported. This retrospective study was conducted to evaluate the incidence, severity, and risk factors of symptomat...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ac1d2e6abb474baab5f2a2c63217a8f9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|